178 related articles for article (PubMed ID: 36579974)
1. Treatment patterns in women with urinary urgency and/or urgency urinary incontinence in the symptoms of Lower Urinary Tract Dysfunction Research Network Observational Cohort Study.
Bretschneider CE; Liu Q; Smith AR; Kirkali Z; Amundsen CL; Lai H; Geynisman-Tan J; Kirby A; Cameron AP; Helmuth ME; Griffith JW; Jelovsek JE;
Neurourol Urodyn; 2023 Jan; 42(1):194-204. PubMed ID: 36579974
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of models predicting treatment patterns in women with urinary urgency and/or urgency incontinence: A Symptoms of Lower Urinary Tract Dysfunction Research Network observational cohort study.
Bretschneider CE; Liu Q; Smith AR; Mansfield SA; Kirkali Z; Amundsen CL; Lai HHH; Geynisman-Tan J; Kirby A; Jelovsek JE;
Neurourol Urodyn; 2023 Aug; 42(6):1214-1226. PubMed ID: 37269483
[TBL] [Abstract][Full Text] [Related]
3. What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel.
Farag F; Sakalis VI; Arteaga SM; Sihra N; Karavitakis M; Arlandis S; Bø K; Cobussen-Boekhorst H; Costantini E; de Heide M; Groen J; Peyronnet B; Phé V; van Poelgeest-Pomfret ML; van den Bos TWL; van der Vaart H; Harding CK; Carmela Lapitan M; Imran Omar M; Nambiar AK
Eur Urol; 2023 Sep; 84(3):302-312. PubMed ID: 37331921
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency as the New Opportunity in Treating Overactive Bladder and Urge Urinary Incontinence-A Single-Arm Pilot Study.
Franić D; Franić Ivanišević M; Verdenik I
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399486
[No Abstract] [Full Text] [Related]
5. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
6. Total fluid intake, caffeine, and other bladder irritant avoidance among adults having urinary urgency with and without urgency incontinence: The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).
Cameron AP; Helmuth ME; Smith AR; Lai HH; Amundsen CL; Kirkali Z; Gillespie BW; Yang CC; Clemens JQ;
Neurourol Urodyn; 2023 Jan; 42(1):213-220. PubMed ID: 36579975
[TBL] [Abstract][Full Text] [Related]
7. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
8. Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.
Campbell JD; Gries KS; Watanabe JH; Ravelo A; Dmochowski RR; Sullivan SD
BMC Urol; 2009 Nov; 9():18. PubMed ID: 19930578
[TBL] [Abstract][Full Text] [Related]
9. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women.
Agarwal A; Eryuzlu LN; Cartwright R; Thorlund K; Tammela TL; Guyatt GH; Auvinen A; Tikkinen KA
Eur Urol; 2014 Jun; 65(6):1211-7. PubMed ID: 24486308
[TBL] [Abstract][Full Text] [Related]
10. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
Stewart F; Gameiro LF; El Dib R; Gameiro MO; Kapoor A; Amaro JL
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010098. PubMed ID: 27935011
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
Amundsen CL; Komesu YM; Chermansky C; Gregory WT; Myers DL; Honeycutt EF; Vasavada SP; Nguyen JN; Wilson TS; Harvie HS; Wallace D;
Eur Urol; 2018 Jul; 74(1):66-73. PubMed ID: 29482936
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
[TBL] [Abstract][Full Text] [Related]
14. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of urgency urinary incontinence in the United States: a systematic review.
Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcome of solifenacin treatment among women experiencing urinary urgency and urgency incontinence.
But I; Orešković S; Bratuš D; Šprem-Goldštajn M; Hlebič G
Int J Gynaecol Obstet; 2014 Jan; 124(1):19-23. PubMed ID: 24135289
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting the treatment success of bladder training for urgency urinary incontinence.
Yıldız N; Özlü A
Neurourol Urodyn; 2022 Nov; 41(8):1809-1816. PubMed ID: 35989536
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study.
Goudelocke C; Xavier K; Pecha B; Burgess K; Perrouin-Verbe MA; Krlin R; Michaels J; Shah S; Peyronnet B; Zaslau S; Champs M; Papi B; Bittner K; Elterman D; Nitti V
Neurourol Urodyn; 2023 Apr; 42(4):761-769. PubMed ID: 36917003
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
20. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.
Lee JK; Dwyer PL; Rosamilia A; Lim YN; Polyakov A; Stav K
BJOG; 2011 Jun; 118(7):798-805. PubMed ID: 21392244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
